Protective Role of Oxcarbazepine in Multiple Sclerosis
OxCarbazepine as a Neuroprotective Agent in MS: A Phase 2a Trial
Multiple Sclerosis
Drug: Oxcarbazepine;Drug: Placebo
Queen Mary University of London
National Multiple Sclerosis Society;Novartis Pharmaceuticals;Barts & The London NHS Trust;University College, London;Royal Free Hospital NHS Foundation Trust;Southend University Hospital;Basildon and Thurrock University Hospitals NHS Foundation Trust;St George's Healthcare NHS Trust;Barnet and Chase Farm Hospitals NHS Trust National Multiple Sclerosis Society;Novartis Pharmaceuticals;Barts & The London NHS Trust;University ...
PROXIMUS (PRotective role of OXcabazepine In MUltiple Sclerosis)
Oxcarbazepine as a neuroprotective agent in MS: phase 2a trial - PROXIMUS - PRotective role of OXcabazepine In MUltiple Sclerosis Oxcarbazepineas a neuroprotective agent in MS: phase 2a trial - PROXIMUS - PRotective role of OXcab ...
Trade Name: Trileptal Product Name: Oxcarbazepine INN or Proposed INN: oxcarbazepine Other descriptive name: Trileptal Trade Name: Trileptal Product Name: Oxcarbazepine INN or Proposed INN: oxcarbazepine Other descriptive ...
Queen Mary University London
NULL
Not Recruiting
Female: yes Male: yes
30
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...